Enochian Biosciences, Inc. (ENOB) Earning

NASDAQ Currency in USD Disclaimer

$0.31

Last update: 04:00 PM EST
Day's range
$0.7
Day's range
$0.75
ENOB Earnings Estimates and Actuals by Quarter$0$0-$0.5-$0.5-$1-$1-$1.5-$1.5-$2-$2Q1 2021Q1 2021Q3 2021Q3 2021Q1 2022Q1 2022Q3 2022Q3 2022Q1 2023Q1 2023Q3 2023Q3 2023Q1 2024Q1 2024Q3 2024Q3 2024
Actual EPS
Download SVG
Download PNG
Download CSV

Enochian Biosciences, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
05/15/2025 Q3 2024 N/A $0.00 N/A N/A $0
02/19/2025 Q2 2024 N/A -$0.04 N/A N/A $0
02/19/2025 Q1 2024 N/A -$0.28 N/A N/A $0
10/28/2024 Q4 2023 N/A -$0.16 N/A N/A $181.45 K
08/20/2024 Q3 2023 N/A -$0.16 N/A N/A $0
12/30/2023 Q2 2023 N/A -$0.07 N/A N/A $0
09/29/2023 Q1 2023 N/A -$0.14 N/A N/A $0
06/29/2023 Q4 2022 N/A -$0.36 N/A N/A $0
03/30/2023 Q3 2022 N/A -$0.08 N/A N/A $0
12/30/2022 Q2 2022 N/A -$0.08 N/A N/A $0
09/29/2022 Q1 2022 N/A -$0.14 N/A N/A $0
06/28/2022 Q4 2021 N/A -$1.70 N/A N/A $0
03/29/2022 Q3 2021 N/A -$0.12 N/A N/A $0
12/29/2021 Q2 2021 N/A -$0.13 N/A N/A $0
09/28/2021 Q1 2021 N/A -$0.20 N/A N/A $0
06/30/2021 Q4 2020 N/A $0.00 N/A N/A $0
03/31/2021 Q3 2020 N/A -$0.09 N/A N/A $0
12/31/2020 Q2 2020 N/A -$0.06 N/A N/A $0
09/30/2020 Q1 2020 N/A -$0.05 N/A N/A $0
06/30/2020 Q4 2019 N/A $0.00 N/A N/A $0

Enochian Biosciences, Inc. Earnings: FAQ's

Enochian Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 8th, 2023 based offlast year's report dates.

The conference call for Enochian Biosciences, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Enochian Biosciences, Inc.'s latest earnings report can be read online.

Enochian Biosciences, Inc. (:ENOB) has a recorded net income of $-80,650,172.Enochian Biosciences, Inc. has generated $-0.84 earnings per share over the last four quarters.

Enochian Biosciences, Inc. (:ENOB) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is -0.03.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED